Global and United States Intravenous (IV) Ibuprofen Market Report & Forecast 2022-2028

Publisher Name :
Date: 01-Jun-2022
No. of pages: 101
Inquire Before Buying

Intravenous (IV) Ibuprofen market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Intravenous (IV) Ibuprofen market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

- 100 mg Dose

- 200 mg Dose

- 400 mg Dose

- 800 mg Dose

Segment by Application

- Pain

- Fever

- Inflammation

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Cumberland Pharmaceuticals

- Alveda Pharmaceuticals

- CSL Limited

- Sandor Medicaids

- PT. Soho Industri Pharmasi

- Germin MED

- Grifols

- Gloria Pharmaceuticals

- Al Nabeel International

- Laboratorios Valmorca

Global and United States Intravenous (IV) Ibuprofen Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Intravenous (IV) Ibuprofen Product Introduction
1.2 Global Intravenous (IV) Ibuprofen Outlook 2017 VS 2022 VS 2028
1.2.1 Global Intravenous (IV) Ibuprofen Sales in US$ Million for the Year 2017-2028
1.2.2 Global Intravenous (IV) Ibuprofen Sales in Volume for the Year 2017-2028
1.3 United States Intravenous (IV) Ibuprofen Outlook 2017 VS 2022 VS 2028
1.3.1 United States Intravenous (IV) Ibuprofen Sales in US$ Million for the Year 2017-2028
1.3.2 United States Intravenous (IV) Ibuprofen Sales in Volume for the Year 2017-2028
1.4 Intravenous (IV) Ibuprofen Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Intravenous (IV) Ibuprofen in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Intravenous (IV) Ibuprofen Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Intravenous (IV) Ibuprofen Market Dynamics
1.5.1 Intravenous (IV) Ibuprofen Industry Trends
1.5.2 Intravenous (IV) Ibuprofen Market Drivers
1.5.3 Intravenous (IV) Ibuprofen Market Challenges
1.5.4 Intravenous (IV) Ibuprofen Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Intravenous (IV) Ibuprofen Market Segment by Type
2.1.1 100 mg Dose
2.1.2 200 mg Dose
2.1.3 400 mg Dose
2.1.4 800 mg Dose
2.2 Global Intravenous (IV) Ibuprofen Market Size by Type
2.2.1 Global Intravenous (IV) Ibuprofen Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Intravenous (IV) Ibuprofen Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Intravenous (IV) Ibuprofen Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Intravenous (IV) Ibuprofen Market Size by Type
2.3.1 United States Intravenous (IV) Ibuprofen Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Intravenous (IV) Ibuprofen Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Intravenous (IV) Ibuprofen Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Intravenous (IV) Ibuprofen Market Segment by Application
3.1.1 Pain
3.1.2 Fever
3.1.3 Inflammation
3.2 Global Intravenous (IV) Ibuprofen Market Size by Application
3.2.1 Global Intravenous (IV) Ibuprofen Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Intravenous (IV) Ibuprofen Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Intravenous (IV) Ibuprofen Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Intravenous (IV) Ibuprofen Market Size by Application
3.3.1 United States Intravenous (IV) Ibuprofen Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Intravenous (IV) Ibuprofen Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Intravenous (IV) Ibuprofen Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Intravenous (IV) Ibuprofen Competitor Landscape by Company
4.1 Global Intravenous (IV) Ibuprofen Market Size by Company
4.1.1 Top Global Intravenous (IV) Ibuprofen Manufacturers Ranked by Revenue (2021)
4.1.2 Global Intravenous (IV) Ibuprofen Revenue by Manufacturer (2017-2022)
4.1.3 Global Intravenous (IV) Ibuprofen Sales by Manufacturer (2017-2022)
4.1.4 Global Intravenous (IV) Ibuprofen Price by Manufacturer (2017-2022)
4.2 Global Intravenous (IV) Ibuprofen Concentration Ratio (CR)
4.2.1 Intravenous (IV) Ibuprofen Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Intravenous (IV) Ibuprofen in 2021
4.2.3 Global Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Intravenous (IV) Ibuprofen Manufacturing Base Distribution, Product Type
4.3.1 Global Intravenous (IV) Ibuprofen Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Intravenous (IV) Ibuprofen Product Type
4.3.3 Date of International Manufacturers Enter into Intravenous (IV) Ibuprofen Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Intravenous (IV) Ibuprofen Market Size by Company
4.5.1 Top Intravenous (IV) Ibuprofen Players in United States, Ranked by Revenue (2021)
4.5.2 United States Intravenous (IV) Ibuprofen Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Intravenous (IV) Ibuprofen Sales by Players (2020, 2021 & 2022)
5 Global Intravenous (IV) Ibuprofen Market Size by Region
5.1 Global Intravenous (IV) Ibuprofen Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Intravenous (IV) Ibuprofen Market Size in Volume by Region (2017-2028)
5.2.1 Global Intravenous (IV) Ibuprofen Sales in Volume by Region: 2017-2022
5.2.2 Global Intravenous (IV) Ibuprofen Sales in Volume Forecast by Region (2023-2028)
5.3 Global Intravenous (IV) Ibuprofen Market Size in Value by Region (2017-2028)
5.3.1 Global Intravenous (IV) Ibuprofen Sales in Value by Region: 2017-2022
5.3.2 Global Intravenous (IV) Ibuprofen Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Intravenous (IV) Ibuprofen Market Size YoY Growth 2017-2028
6.1.2 North America Intravenous (IV) Ibuprofen Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Intravenous (IV) Ibuprofen Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Intravenous (IV) Ibuprofen Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Intravenous (IV) Ibuprofen Market Size YoY Growth 2017-2028
6.3.2 Europe Intravenous (IV) Ibuprofen Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Intravenous (IV) Ibuprofen Market Size YoY Growth 2017-2028
6.4.2 Latin America Intravenous (IV) Ibuprofen Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Intravenous (IV) Ibuprofen Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Intravenous (IV) Ibuprofen Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Cumberland Pharmaceuticals
7.1.1 Cumberland Pharmaceuticals Corporation Information
7.1.2 Cumberland Pharmaceuticals Description and Business Overview
7.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
7.1.5 Cumberland Pharmaceuticals Recent Development
7.2 Alveda Pharmaceuticals
7.2.1 Alveda Pharmaceuticals Corporation Information
7.2.2 Alveda Pharmaceuticals Description and Business Overview
7.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
7.2.5 Alveda Pharmaceuticals Recent Development
7.3 CSL Limited
7.3.1 CSL Limited Corporation Information
7.3.2 CSL Limited Description and Business Overview
7.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.3.4 CSL Limited Intravenous (IV) Ibuprofen Products Offered
7.3.5 CSL Limited Recent Development
7.4 Sandor Medicaids
7.4.1 Sandor Medicaids Corporation Information
7.4.2 Sandor Medicaids Description and Business Overview
7.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Products Offered
7.4.5 Sandor Medicaids Recent Development
7.5 PT. Soho Industri Pharmasi
7.5.1 PT. Soho Industri Pharmasi Corporation Information
7.5.2 PT. Soho Industri Pharmasi Description and Business Overview
7.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Products Offered
7.5.5 PT. Soho Industri Pharmasi Recent Development
7.6 Germin MED
7.6.1 Germin MED Corporation Information
7.6.2 Germin MED Description and Business Overview
7.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Germin MED Intravenous (IV) Ibuprofen Products Offered
7.6.5 Germin MED Recent Development
7.7 Grifols
7.7.1 Grifols Corporation Information
7.7.2 Grifols Description and Business Overview
7.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Grifols Intravenous (IV) Ibuprofen Products Offered
7.7.5 Grifols Recent Development
7.8 Gloria Pharmaceuticals
7.8.1 Gloria Pharmaceuticals Corporation Information
7.8.2 Gloria Pharmaceuticals Description and Business Overview
7.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
7.8.5 Gloria Pharmaceuticals Recent Development
7.9 Al Nabeel International
7.9.1 Al Nabeel International Corporation Information
7.9.2 Al Nabeel International Description and Business Overview
7.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Products Offered
7.9.5 Al Nabeel International Recent Development
7.10 Laboratorios Valmorca
7.10.1 Laboratorios Valmorca Corporation Information
7.10.2 Laboratorios Valmorca Description and Business Overview
7.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Products Offered
7.10.5 Laboratorios Valmorca Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Intravenous (IV) Ibuprofen Industry Chain Analysis
8.2 Intravenous (IV) Ibuprofen Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Intravenous (IV) Ibuprofen Distributors
8.3 Intravenous (IV) Ibuprofen Production Mode & Process
8.4 Intravenous (IV) Ibuprofen Sales and Marketing
8.4.1 Intravenous (IV) Ibuprofen Sales Channels
8.4.2 Intravenous (IV) Ibuprofen Distributors
8.5 Intravenous (IV) Ibuprofen Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Intravenous (IV) Ibuprofen CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Intravenous (IV) Ibuprofen Market Trends
Table 3. Intravenous (IV) Ibuprofen Market Drivers
Table 4. Intravenous (IV) Ibuprofen Market Challenges
Table 5. Intravenous (IV) Ibuprofen Market Restraints
Table 6. Global Intravenous (IV) Ibuprofen Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Intravenous (IV) Ibuprofen Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Intravenous (IV) Ibuprofen Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Intravenous (IV) Ibuprofen Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Intravenous (IV) Ibuprofen Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Intravenous (IV) Ibuprofen Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Intravenous (IV) Ibuprofen Revenue Share by Manufacturer, 2017-2022
Table 13. Global Intravenous (IV) Ibuprofen Sales by Manufacturer, (MT), 2017-2022
Table 14. Global Intravenous (IV) Ibuprofen Sales Share by Manufacturer, 2017-2022
Table 15. Global Intravenous (IV) Ibuprofen Price by Manufacturer (2017-2022) & (USD/Kg)
Table 16. Global Intravenous (IV) Ibuprofen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Intravenous (IV) Ibuprofen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Ibuprofen as of 2021)
Table 18. Top Players of Intravenous (IV) Ibuprofen in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Intravenous (IV) Ibuprofen Product Type
Table 20. Date of International Manufacturers Enter into Intravenous (IV) Ibuprofen Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Intravenous (IV) Ibuprofen Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Intravenous (IV) Ibuprofen Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Intravenous (IV) Ibuprofen Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Intravenous (IV) Ibuprofen Sales by Players, (MT), 2020, 2021 & 2022
Table 26. United States Intravenous (IV) Ibuprofen Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Intravenous (IV) Ibuprofen Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Intravenous (IV) Ibuprofen Sales in Volume by Region (2017-2022) & (MT)
Table 29. Global Intravenous (IV) Ibuprofen Sales in Volume Forecast by Region (2023-2028) & (MT)
Table 30. Global Intravenous (IV) Ibuprofen Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Intravenous (IV) Ibuprofen Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Intravenous (IV) Ibuprofen Sales in Volume by Country (2017-2028) & (MT)
Table 33. North America Intravenous (IV) Ibuprofen Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Intravenous (IV) Ibuprofen Sales in Volume by Region (2017-2028) & (MT)
Table 35. Asia Pacific Intravenous (IV) Ibuprofen Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Intravenous (IV) Ibuprofen Sales in Volume by Country (2017-2028) & (MT)
Table 37. Europe Intravenous (IV) Ibuprofen Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Intravenous (IV) Ibuprofen Sales in Volume by Country (2017-2028) & (MT)
Table 39. Latin Americaa Intravenous (IV) Ibuprofen Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Intravenous (IV) Ibuprofen Sales in Volume by Country (2017-2028) & (MT)
Table 41. Middle East and Africa Intravenous (IV) Ibuprofen Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Cumberland Pharmaceuticals Corporation Information
Table 43. Cumberland Pharmaceuticals Description and Business Overview
Table 44. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 45. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product
Table 46. Cumberland Pharmaceuticals Recent Development
Table 47. Alveda Pharmaceuticals Corporation Information
Table 48. Alveda Pharmaceuticals Description and Business Overview
Table 49. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 50. Alveda Pharmaceuticals Product
Table 51. Alveda Pharmaceuticals Recent Development
Table 52. CSL Limited Corporation Information
Table 53. CSL Limited Description and Business Overview
Table 54. CSL Limited Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 55. CSL Limited Product
Table 56. CSL Limited Recent Development
Table 57. Sandor Medicaids Corporation Information
Table 58. Sandor Medicaids Description and Business Overview
Table 59. Sandor Medicaids Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 60. Sandor Medicaids Product
Table 61. Sandor Medicaids Recent Development
Table 62. PT. Soho Industri Pharmasi Corporation Information
Table 63. PT. Soho Industri Pharmasi Description and Business Overview
Table 64. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 65. PT. Soho Industri Pharmasi Product
Table 66. PT. Soho Industri Pharmasi Recent Development
Table 67. Germin MED Corporation Information
Table 68. Germin MED Description and Business Overview
Table 69. Germin MED Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 70. Germin MED Product
Table 71. Germin MED Recent Development
Table 72. Grifols Corporation Information
Table 73. Grifols Description and Business Overview
Table 74. Grifols Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 75. Grifols Product
Table 76. Grifols Recent Development
Table 77. Gloria Pharmaceuticals Corporation Information
Table 78. Gloria Pharmaceuticals Description and Business Overview
Table 79. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 80. Gloria Pharmaceuticals Product
Table 81. Gloria Pharmaceuticals Recent Development
Table 82. Al Nabeel International Corporation Information
Table 83. Al Nabeel International Description and Business Overview
Table 84. Al Nabeel International Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 85. Al Nabeel International Product
Table 86. Al Nabeel International Recent Development
Table 87. Laboratorios Valmorca Corporation Information
Table 88. Laboratorios Valmorca Description and Business Overview
Table 89. Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 90. Laboratorios Valmorca Product
Table 91. Laboratorios Valmorca Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Intravenous (IV) Ibuprofen Customers List
Table 95. Intravenous (IV) Ibuprofen Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous (IV) Ibuprofen Product Picture
Figure 2. Global Intravenous (IV) Ibuprofen Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Intravenous (IV) Ibuprofen Market Size 2017-2028 (US$ Million)
Figure 4. Global Intravenous (IV) Ibuprofen Sales 2017-2028 (MT)
Figure 5. United States Intravenous (IV) Ibuprofen Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Intravenous (IV) Ibuprofen Market Size 2017-2028 (US$ Million)
Figure 7. United States Intravenous (IV) Ibuprofen Sales 2017-2028 (MT)
Figure 8. United States Intravenous (IV) Ibuprofen Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Intravenous (IV) Ibuprofen Market Share in Global, in Volume (MT) 2017-2028
Figure 10. Intravenous (IV) Ibuprofen Report Years Considered
Figure 11. Product Picture of 100 mg Dose
Figure 12. Product Picture of 200 mg Dose
Figure 13. Product Picture of 400 mg Dose
Figure 14. Product Picture of 800 mg Dose
Figure 15. Global Intravenous (IV) Ibuprofen Market Share by Type in 2022 & 2028
Figure 16. Global Intravenous (IV) Ibuprofen Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Intravenous (IV) Ibuprofen Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Intravenous (IV) Ibuprofen Sales by Type (2017-2028) & (MT)
Figure 19. Global Intravenous (IV) Ibuprofen Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Intravenous (IV) Ibuprofen Price by Type (2017-2028) & (USD/Kg)
Figure 21. United States Intravenous (IV) Ibuprofen Market Share by Type in 2022 & 2028
Figure 22. United States Intravenous (IV) Ibuprofen Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Intravenous (IV) Ibuprofen Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Intravenous (IV) Ibuprofen Sales by Type (2017-2028) & (MT)
Figure 25. United States Intravenous (IV) Ibuprofen Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Intravenous (IV) Ibuprofen Price by Type (2017-2028) & (USD/Kg)
Figure 27. Product Picture of Pain
Figure 28. Product Picture of Fever
Figure 29. Product Picture of Inflammation
Figure 30. Global Intravenous (IV) Ibuprofen Market Share by Application in 2022 & 2028
Figure 31. Global Intravenous (IV) Ibuprofen Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Intravenous (IV) Ibuprofen Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Intravenous (IV) Ibuprofen Sales by Application (2017-2028) & (MT)
Figure 34. Global Intravenous (IV) Ibuprofen Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Intravenous (IV) Ibuprofen Price by Application (2017-2028) & (USD/Kg)
Figure 36. United States Intravenous (IV) Ibuprofen Market Share by Application in 2022 & 2028
Figure 37. United States Intravenous (IV) Ibuprofen Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Intravenous (IV) Ibuprofen Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Intravenous (IV) Ibuprofen Sales by Application (2017-2028) & (MT)
Figure 40. United States Intravenous (IV) Ibuprofen Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Intravenous (IV) Ibuprofen Price by Application (2017-2028) & (USD/Kg)
Figure 42. North America Intravenous (IV) Ibuprofen Sales in Volume Growth Rate 2017-2028 (MT)
Figure 43. North America Intravenous (IV) Ibuprofen Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Intravenous (IV) Ibuprofen Sales in Volume Growth Rate 2017-2028 (MT)
Figure 47. Europe Intravenous (IV) Ibuprofen Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Intravenous (IV) Ibuprofen Sales in Volume Growth Rate 2017-2028 (MT)
Figure 54. Asia-Pacific Intravenous (IV) Ibuprofen Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Intravenous (IV) Ibuprofen Sales in Volume Growth Rate 2017-2028 (MT)
Figure 66. Latin America Intravenous (IV) Ibuprofen Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Intravenous (IV) Ibuprofen Sales in Volume Growth Rate 2017-2028 (MT)
Figure 71. Middle East & Africa Intravenous (IV) Ibuprofen Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Intravenous (IV) Ibuprofen Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Intravenous (IV) Ibuprofen Value Chain
Figure 76. Intravenous (IV) Ibuprofen Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs